Everything below concerns bioavailability. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-04-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Generally, when reactions take place in the liquid and solid phases the change in volume due to reaction is not significant enough that it needs to be taken into account. Reactions in the gas phase often have significant changes in volume and in these cases one should use these modified equations.
John Rodker (18 December 1894 – 6 October 1955) was an English writer, modernist poet, and publisher of modernist writers and one of the "Whitechapel Boys", a group including Isaac Rosenberg, Mark Gertler, David Bomberg, Samuel Weinstein and Joseph Lefkowitz Herbert Rosenfeld (1910–1986); German Jewish British psychoanalyst; made seminal contributions to Kleinian thinking on psychotic and other very ill patients; has had wide impact on analysts both in Britain and internationally, exploring projective identification and theory of destructive narcissism. Adele Rose (8 December 1933 – 28 December 2020) was an English television writer. She was the longest-serving scriptwriter for the soap opera Coronation Street, writing 457 scripts over a period of 37 years from 1961, and was the first woman to write for the show. She also originated the series Byker Grove (1989–2006), aimed at teenagers. Gillian Rose; (20 September 1947 – 9 December 1995) philosopher and writer; held chair of social and political thought at the University of Warwick; taught at University of Sussex; worked in fields of philosophy and sociology, neo-Kantianism, post-modernism, political theology, speculative thought." Hilary Rose (sociologist) (born 1935) is a British sociologist and author of over ten books and more than 150 scholarly articles and papers; critic of Israel, Zionism and the continued settlement, colonisation and occupation of Palestinian land, calling for Academic boycott of Israel.
=== University of Nebraska Medical Center === Markin was awarded the Ida Ittner Postdoctoral Fellowship studying lead toxicity in children from 1980 to 1982, working in the laboratory of Dr. Carol R. Angle. In 2005, Markin was named the David T. Purtilo Professor of Pathology and Microbiology. Markin helped develop Children's Specialty Physicians, the pediatric practice plan for the UNMC College of Medicine at Children's Hospital & Medical Center. Markin also holds appointments in the Departments of Surgery and Psychiatry. Markin was inducted into the National Academy of Inventors Fellows Class of 2015. He has also received the Lifetime Achievement Award from UNeMed Corporation, UNMC's technology transfer office, for his innovations that have transformed the clinical laboratory. Markin leads the telehealth initiative of UNMC and Nebraska Medicine. Since 2011, he has served as associate vice chancellor for business development and as chief technology officer. In October 2005, the U.S. Defense Department provided a grant to Markin and his team to design a new method for microbiology automation. Known as the Microbiology Automation Research Project, or "MARP," the project is designed to develop a broad platform that can be used in the clinical laboratory, including applications for bacteriology, mycology and virology. Additionally, the project has potential uses for other applications, including bioterrorism testing, and holds significant promise for the civilian sector. Markin holds several patents, and has written numerous industry articles on laboratory automation.
Sources: en.wikipedia.org
At a hearing at the Old Bailey, Nathan Gill, the former leader of Reform UK in Wales, pleads guilty to eight counts of bribery relating to a pro-Russian influence campaign in the European Parliament during 2018 and 2019. 21 November – At the Old Bailey, Nathan Gill, former UKIP and later Reform UK leader in Wales, is sentenced to 10 and a half years in prison for accepting Russian bribes while in the European Parliament during 2018 and 2019. Former cabinet minister Michael Gove apologises on behalf of the UK government and Conservative Party for "mistakes made" during the COVID-19 pandemic. Iqbal Mohamed becomes the second MP to announce they are leaving the new left-wing party provisionally known as Your Party. 24 November – Richard Dannatt and David Evans are scheduled to be suspended from the House of Lords for breaching parliamentary rules, including providing parliamentary services in return for "payment or reward". Addressing allegations made about him from his schooldays, Farage says he has "never directly racially abused anybody". Addressing his party's potential links to Russia, Farage says that Reform does not have the resources to investigate the matter. 26 November – The Chancellor of the Exchequer, Rachel Reeves delivers the 2025 United Kingdom budget. 27 November – Former Brexit Party MEP David Coburn, who is named in a series of WhatsApp messages, rejects allegations he participated in a pro-Russian influence campaign in the European Parliament.
Sudden immersion into freezing water does not typically cause death by hypothermia, but rather from the cold shock response, which can cause cardiac arrest, heart attack, or hyperventilation leading to drowning. Cremated remains are not ashes in the usual sense. After the incineration is completed, the dry bone fragments are swept out of the retort and pulverized by a machine called a cremulator (essentially a high-capacity, high-speed blender) to process them into "ashes" or "cremated remains".
An open-faced, or Lépine, watch, is one in which the case lacks a metal cover to protect the crystal. It is typical for an open-faced watch to have the pendant located at 12:00 and the sub-second dial located at 6:00. Occasionally, a watch movement intended for a hunting case (with the winding stem at 3:00 and sub second dial at 6:00) will have an open-faced case. Such watch is known as a "sidewinder." Alternatively, such a watch movement may be fitted with a so-called conversion dial, which relocates the winding stem to 12:00 and the sub-second dial to 3:00. After 1908, watches approved for railroad service were required to be cased in open-faced cases with the winding stem at 12:00.
=== Seizures === Levetiracetam is an anti-epileptic drug than can be used to treat partial and generalized seizures. Levetiracetam inhibits P/Q channel-mediated glutamate release and decreases the excitatory post synaptic currents of both AMPA and NMDA receptors in the hippocampus, specifically the dentate gyrus, which is known to propagate seizure activities. The inhibition of glutamate release results in an anti-epileptic response in patients because it decreases the excitatory postsynaptic current. There are many different types of calcium channels, so to prove that the P/Q type calcium channels are directly involved, a P/Q type voltage gated calcium channel inhibitor, omega-agatoxin TK, was used to block the channel. When blocked, patients no longer benefited from the anti-epileptic effects from the drugs. When blockers for L type and N type calcium channels were used, the effects of Levetiracetam were still seen. This is strong evidence that the P/Q type calcium channels are involved in the Levetiracetam treatment which allow for relief from seizures.
Sources: en.wikipedia.org
=== Mechanism === RIP causes G:C to A:T transition mutations within repeats, however, the mechanism that detects the repeated sequences is unknown. RID is the only known protein essential for RIP. It is a DNA methyltransferease-like protein, that when mutated or knocked out results in loss of RIP. Deletion of the rid homolog in Aspergillus nidulans, dmtA, results in loss of fertility while deletion of the rid homolog in Ascobolus immersens, masc1, results in fertility defects and loss of methylation induced premeiotically (MIP).
{\displaystyle {\boldsymbol {\sigma }}=-p\mathbf {I} +\mu \left(\nabla \mathbf {u} +(\nabla \mathbf {u} )^{\mathrm {T} }\right)+\left(\zeta -{\frac {2}{3}}\mu \right)(\nabla \cdot \mathbf {u} )\mathbf {I} .}
== Early life == Ryder is of Noongar heritage and was raised in Geraldton, Western Australia. He began playing junior football with the Rover Football Club at Greenough Oval. Ryder was part of the AFL under-18 All-Australian team and represented Australia in the under-18 international rules in Ireland. Prior to being drafted, he played in the West Australian Football League (WAFL), playing for the East Fremantle Football Club.
==== Fiction that references Jung's theories ==== Hermann Hesse, author of works such as Siddhartha and Steppenwolf, was treated by Joseph Lang, a student of Jung. For Hesse this began a long preoccupation with psychoanalysis, through which he came to know Jung personally. The Canadian novelist Robertson Davies made Jungian analysis a central part of his 1970 novel The Manticore. He stated in a letter, "There have been other books which describe Freudian analyses, but I know of no other that describes a Jungian analysis" adding "I was deeply afraid that I would put my foot in it, for I have never undergone one of those barnacle-scraping experiences, and knew of it only through reading. So, I was greatly pleased when some of my Jungian friends in Zurich liked it very much." The psychological novel E.E. written by Olga Tokarczuk draws from Jung's doctoral dissertation On the Psychology and Pathology of So-Called Occult Phenomena. Jung is not a character in this story, but Jung's views on the occult are extensively cited.
To fix carbon dioxide into sugar molecules in the process of photosynthesis, chloroplasts use an enzyme called RuBisCO. RuBisCO has trouble distinguishing between carbon dioxide and oxygen, so at high oxygen concentrations, RuBisCO starts accidentally adding oxygen to sugar precursors. This has the result of ATP energy being wasted and CO2 being released, all with no sugar being produced. This is a big problem, since O2 is produced by the initial light reactions of photosynthesis, causing issues down the line in the Calvin cycle which uses RuBisCO. C4 plants evolved a way to solve this—by spatially separating the light reactions and the Calvin cycle. The light reactions, which store light energy in ATP and NADPH, are done in the mesophyll cells of a C4 leaf. The Calvin cycle, which uses the stored energy to make sugar using RuBisCO, is done in the bundle sheath cells, a layer of cells surrounding a vein in a leaf. As a result, chloroplasts in C4 mesophyll cells and bundle sheath cells are specialized for each stage of photosynthesis. In mesophyll cells, chloroplasts are specialized for the light reactions, so they lack RuBisCO, and have normal grana and thylakoids, which they use to make ATP and NADPH, as well as oxygen. They store CO2 in a four-carbon compound, which is why the process is called C4 photosynthesis. The four-carbon compound is then transported to the bundle sheath chloroplasts, where it drops off CO2 and returns to the mesophyll.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.